Showing results (31-40 of 795) with videos related to
Sort By:
Pageof 80
Clinical Pharmacology and Therapeutics|March 1, 1980
Intranasal and oral cocaine kineticsP Wilkinson, C Van Dyke, P Jatlow, et al.Psychiatry Research|July 1, 1980
Platelet MAO and amitriptyline treatmentE Giller, P Jatlow, D Bialos, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)E F McCance-Katz, P M Rainey, P Jatlow, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeysC W Bradberry, R L Barrett-Larimore, P Jatlow, et al.Science (New York, N.Y.)|April 14, 1978
Oral cocaine: plasma concentrations and central effectsC Van Dyke, P Jatlow, J Ungerer, et al.Psychopharmacology|May 11, 2000
Comparison of intravenous cocaethylene and cocaine in humansC L Hart, P Jatlow, K A Sevarino, et al.Anesthesia and Analgesia|May 1, 1979
Cocaine and succinylcholine sensitivity: a new cautionP Jatlow, P G Barash, C Van Dyke, et al.Archives of General Psychiatry|July 30, 2003
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadoneA H Oliveto, A Feingold, R Schottenfeld, et al.Life Sciences|March 1, 1982
Plasma cocaine concentrations during cocaine paste smokingD Paly, P Jatlow, C Van Dyke, et al.The American Journal of Drug and Alcohol Abuse|January 1, 1990
Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuseT R Kosten, F H Gawin, C Morgan, et al.Pageof 80